OverviewChartTechnicalNewsTraderScreen

Supernus Pharmaceuticals Inc/  US8684591089  /

NASDAQ
2024-10-07  10:00:00 PM Chg. +0.0400 Volume Bid12:33:46 AM Ask12:33:46 AM High Low
32.0600USD +0.12% 190,954
Turnover: 3.96 mill.		 31.2100Bid Size: 100 32.8800Ask Size: 100 32.2200 31.3600
GlobeNewswire 08-28 Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
GlobeNewswire 08-19 Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
GlobeNewswire 08-06 Supernus Announces Second Quarter 2024 Financial Results
GlobeNewswire 08-01 Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
GlobeNewswire 07-23 Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call ...
GlobeNewswire 05-30 Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 05-23 Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epile...
GlobeNewswire 05-21 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 05-12 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 05-09 Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa St...
GlobeNewswire 05-08 Supernus Announces First Quarter 2024 Financial Results
GlobeNewswire 05-02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 05-01 Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
GlobeNewswire 04-24 Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call o...
GlobeNewswire 04-24 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmac...
GlobeNewswire 04-08 Supernus Provides Regulatory Update for SPN-830
GlobeNewswire 03-26 MannKind Announces CFO Transition
GlobeNewswire 03-06 Supernus to Participate in Two Upcoming Investor Conferences
GlobeNewswire 02-28 Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
GlobeNewswire 02-27 Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-13 Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Co...
GlobeNewswire 02-05 Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent
GlobeNewswire 02-02 SAB Biotherapeutics Announces Executive Leadership Change
GlobeNewswire 2023-11-08 Supernus Announces Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-07 Supernus to Participate in the Jefferies London Healthcare Conference